Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Amrita Krishnan, MD, City of Hope, Duarte, CA, shares her insights into advancements in drugs used to treat multiple myeloma. Dr Krishnan draws focus on how treatment options are changing, using bispecific antibodies targeting novel targets such as GPRC5D as an example. This interview took place at the 63rd ASH Annual Meeting and Exposition, Atlanta, 2021.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.